These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15202480)

  • 61. Bibliography. Current world literature. Nutrition and metabolism.
    Curr Opin Lipidol; 2009 Feb; 20(1):63-72. PubMed ID: 19106709
    [No Abstract]   [Full Text] [Related]  

  • 62. Bibliography. Current world literature. Andrology, sexual dysfunction and infertility.
    Curr Opin Urol; 2006 Nov; 16(6):463-5. PubMed ID: 17146898
    [No Abstract]   [Full Text] [Related]  

  • 63. Bibliography. Current world literature. Genetics and Molecular Biology.
    Curr Opin Lipidol; 2005 Apr; 16(2):215-41. PubMed ID: 15767862
    [No Abstract]   [Full Text] [Related]  

  • 64. Bibliography--editors' selection of current world literature.
    Coron Artery Dis; 2009 Jun; 20(4):300-2. PubMed ID: 19440069
    [No Abstract]   [Full Text] [Related]  

  • 65. Bibliography. Current world literature. Sexually transmitted diseases and urinary tract infections.
    Curr Opin Infect Dis; 2007 Feb; 20(1):105-14. PubMed ID: 17294570
    [No Abstract]   [Full Text] [Related]  

  • 66. Noncompliance in cardiovascular clinical trials.
    Serebruany VL; Oshrine BR; Malinin AI; Atar D; Michelson AD; Ferguson JJ
    Am Heart J; 2005 Nov; 150(5):882-6. PubMed ID: 16290953
    [No Abstract]   [Full Text] [Related]  

  • 67. [Cardiovascular prevention and large clinical trials].
    Gueyffier F
    Rev Prat; 2005 Oct; 55(16):1774-82. PubMed ID: 16363427
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bibliography of the current world literature.
    J Cardiovasc Risk; 1994 Dec; 1(4):361-74. PubMed ID: 7621320
    [No Abstract]   [Full Text] [Related]  

  • 69. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
    Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
    Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical trials in stem cell therapy: pitfalls and lessons for the future.
    Metharom P; Doyle B; Caplice NM
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4 Suppl 1():S96-9. PubMed ID: 17230223
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bibliography. Current world literature. Genetics and molecular biology.
    Curr Opin Lipidol; 2008 Apr; 19(2):168-200. PubMed ID: 18388697
    [No Abstract]   [Full Text] [Related]  

  • 72. Renal and cardiovascular events: do they deserve the same consideration in clinical trials?
    Ruilope LM; Segura J; Fujita T; Ritz E
    J Hypertens; 2009 Sep; 27(9):1743-5. PubMed ID: 19584754
    [No Abstract]   [Full Text] [Related]  

  • 73. [Equivalence studies in cardiovascular diseases].
    Barbieri P; Marubini E
    Ital Heart J Suppl; 2004 Apr; 5(4):267-75. PubMed ID: 15346693
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gene therapy clinical trials worldwide to 2007--an update.
    Edelstein ML; Abedi MR; Wixon J
    J Gene Med; 2007 Oct; 9(10):833-42. PubMed ID: 17721874
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Therapy and clinical trials.
    Cramb R
    Curr Opin Lipidol; 2007 Feb; 18(1):117-9. PubMed ID: 17218841
    [No Abstract]   [Full Text] [Related]  

  • 76. Targeting the Nrf2 pathway against cardiovascular disease.
    Li J; Ichikawa T; Janicki JS; Cui T
    Expert Opin Ther Targets; 2009 Jul; 13(7):785-94. PubMed ID: 19530984
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical trials in cardiovascular medicine in an era of marginal benefit, bias, and hyperbole.
    Loscalzo J
    Circulation; 2005 Nov; 112(20):3026-9. PubMed ID: 16286598
    [No Abstract]   [Full Text] [Related]  

  • 78. Therapy and clinical trials.
    Cramb R
    Curr Opin Lipidol; 2006 Jun; 17(3):372-4. PubMed ID: 16680044
    [No Abstract]   [Full Text] [Related]  

  • 79. Unconventional end points in cardiovascular clinical trials: should we be moving away from morbidity and mortality?
    Cohn J; Cleland JG; Lubsen J; Borer JS; Steg PG; Perelman M; Zannad F
    J Card Fail; 2009 Apr; 15(3):199-205. PubMed ID: 19327621
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [What future for cardiovascular prevention trials?].
    Scheen AJ
    Rev Med Suisse; 2009 Aug; 5(214):1635-6. PubMed ID: 19772193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.